Blood Journals Portfolio/X
Jul 15, 2025, 07:37
Triple Therapy Breakthrough: Corticosteroids, IVIG, and Platelet Transfusions Transform Management of Critical ITP Bleeding – Blood Journals Portfolio
The Blood Journals Portfolio reported on its official X։
“The combination of corticosteroids, IV immunoglobulin, and platelet transfusion was the most common treatment for critical ITP bleeding.”

This recent report underscores the critical role of combination therapy—corticosteroids, IV immunoglobulin, and platelet transfusion—in effectively managing severe bleeding episodes in immune thrombocytopenia (ITP). It highlights the importance of timely, comprehensive treatment approaches to significantly improve patient outcomes in life-threatening situations.
For more detailed insights on this and other hemostasis topics, visit Hemostasis Today.
American Journal of Hematology
American Society of Hematology
American Thrombosis and Hemostasis Network
ASH
Bleeding management
Blood Journals Portfolio
Corticosteroids
Critical ITP Bleeding
Emergency hematology treatment
Hemostasis therapy
Hemostasis Today
Immune thrombocytopenia
Intravenous Immunoglobulin (IVIG)
ISTH
ITP Treatment
Platelet disorders
Platelet transfusion
Triple Therapy
-
Nov 10, 2025, 10:16Pablo Corral on Enlicitide: The Phase 3 CORALreef HeFH Trial Brings a Major Step Forward
-
Nov 10, 2025, 10:15Laurent Bertoletti Invites You to the Joint INNOVTE and GITA Meeting on Hormones and Thrombosis
-
Nov 10, 2025, 10:15Christopher Cannon: DOAC Monotherapy Wins Again
-
Nov 10, 2025, 10:14Marieke Kruip on Sex differences in Outcomes of VKA Treatment in Patients with Mechanical Heart Valve
-
Nov 10, 2025, 10:14Ana Paula Lacombe: From Research to Bedside, Innovation in Stroke Care is Moving Fast!
-
Nov 10, 2025, 10:13Jan Sloves: Understanding Iliofemoral DVT – What You Can’t Afford to Miss
-
Nov 10, 2025, 10:12Mohamed Rawy Shares a Comprehensive Guide For Anticoagulation
-
Nov 10, 2025, 10:10Marc Carrier: Proud to Share the Results of the WAVe Study
-
Nov 10, 2025, 10:07Frederik Denorme – The New PI at the Laboratory of Cell Biology and Histology at University of Antwerp
